Jennifer C. Learmont

2.3k total citations · 1 hit paper
20 papers, 1.8k citations indexed

About

Jennifer C. Learmont is a scholar working on Infectious Diseases, Virology and Hematology. According to data from OpenAlex, Jennifer C. Learmont has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Virology and 5 papers in Hematology. Recurrent topics in Jennifer C. Learmont's work include HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (6 papers). Jennifer C. Learmont is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (6 papers). Jennifer C. Learmont collaborates with scholars based in Australia, United States and Switzerland. Jennifer C. Learmont's co-authors include John S. Sullivan, Anthony L. Cunningham, Nicholas J. Deacon, John Mills, Suzanne M. Crowe, Catherine Chatfield, Dominic E. Dwyer, D. A. McPhee, Victoria Lawson and Anna Tsykin and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Jennifer C. Learmont

19 papers receiving 1.8k citations

Hit Papers

Genomic Structure of an Attenuated Quasi Species of HIV-1... 1995 2026 2005 2015 1995 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer C. Learmont Australia 13 1.6k 905 714 459 264 20 1.8k
Alison L. Greenway Australia 14 1.4k 0.9× 709 0.8× 747 1.0× 406 0.9× 401 1.5× 23 1.8k
H G Huisman Netherlands 7 1.5k 0.9× 945 1.0× 592 0.8× 253 0.6× 222 0.8× 8 1.6k
Jo Ann M. Mican United States 9 1.9k 1.2× 1.2k 1.3× 1.0k 1.4× 430 0.9× 232 0.9× 10 2.3k
Catherine Chatfield Australia 8 1.2k 0.7× 640 0.7× 537 0.8× 323 0.7× 238 0.9× 8 1.3k
Kristine E. Sheridan United States 7 1.3k 0.8× 638 0.7× 846 1.2× 225 0.5× 253 1.0× 8 1.5k
Anthony Hoffman United States 10 1.1k 0.7× 670 0.7× 764 1.1× 386 0.8× 293 1.1× 11 1.8k
Maarten Koot Netherlands 17 1.7k 1.0× 1.2k 1.3× 684 1.0× 494 1.1× 202 0.8× 20 2.0k
David J. Hooker Australia 10 1.1k 0.7× 668 0.7× 435 0.6× 314 0.7× 247 0.9× 14 1.3k
Åsa Björndal Sweden 16 1.9k 1.2× 1.2k 1.3× 940 1.3× 336 0.7× 383 1.5× 24 2.2k
M Groenink Netherlands 13 1.2k 0.7× 833 0.9× 466 0.7× 200 0.4× 251 1.0× 17 1.4k

Countries citing papers authored by Jennifer C. Learmont

Since Specialization
Citations

This map shows the geographic impact of Jennifer C. Learmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer C. Learmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer C. Learmont more than expected).

Fields of papers citing papers by Jennifer C. Learmont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer C. Learmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer C. Learmont. The network helps show where Jennifer C. Learmont may publish in the future.

Co-authorship network of co-authors of Jennifer C. Learmont

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer C. Learmont. A scholar is included among the top collaborators of Jennifer C. Learmont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer C. Learmont. Jennifer C. Learmont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gray, Lachlan, Melissa J. Churchill, Jasminka Sterjovski, et al.. (2007). Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source. Virology Journal. 4(1). 75–75. 16 indexed citations
3.
Gorry, Paul R., Dale A. McPhee, Erin E. Verity, et al.. (2007). Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology. 4(1). 66–66. 60 indexed citations
4.
Gorry, Paul R., Melissa J. Churchill, Jennifer C. Learmont, et al.. (2007). Replication-Dependent Pathogenicity of Attenuated nef-Deleted HIV-1 In Vivo. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(4). 390–394. 22 indexed citations
5.
Verity, Erin E., Dimitra Zotos, Kim Wilson, et al.. (2007). Viral Phenotypes and Antibody Responses in Long-Term Survivors Infected with Attenuated Human Immunodeficiency Virus Type 1 Containing Deletions in thenefand Long Terminal Repeat Regions. Journal of Virology. 81(17). 9268–9278. 19 indexed citations
6.
Churchill, Melissa J., David I. Rhodes, Jennifer C. Learmont, et al.. (2005). Longitudinal Analysis of Human Immunodeficiency Virus Type 1 nef /Long Terminal Repeat Sequences in a Cohort of Long-Term Survivors Infected from a Single Source. Journal of Virology. 80(2). 1047–1052. 55 indexed citations
7.
Churchill, Melissa J., Jasminka Sterjovski, Lachlan Gray, et al.. (2004). Longitudinal Analysis ofnef/Long Terminal Repeat–Deleted HIV‐1 in Blood and Cerebrospinal Fluid of a Long‐Term Survivor Who Developed HIV‐Associated Dementia. The Journal of Infectious Diseases. 190(12). 2181–2186. 25 indexed citations
8.
Learmont, Jennifer C., et al.. (2002). The value of lookback to understanding blood-borne infectious diseases: The New South Wales' HIV experience. Transfusion Medicine Reviews. 16(4). 315–324. 2 indexed citations
9.
Geczy, Andrew F., Harmjan Kuipers, Marcel W. Coolen, et al.. (2000). HLA and other host factors in transfusion-acquired HIV-1 infection. Human Immunology. 61(2). 172–176. 20 indexed citations
10.
Learmont, Jennifer C., Andrew F. Geczy, John Mills, et al.. (1999). Immunologic and Virologic Status after 14 to 18 Years of Infection with an Attenuated Strain of HIV-1 — A Report from the Sydney Blood Bank Cohort. New England Journal of Medicine. 340(22). 1715–1722. 255 indexed citations
11.
Geczy, Andrew F., et al.. (1999). The Sydney Blood Bank Cohort. Annals of Epidemiology. 9(7). 436–440. 5 indexed citations
13.
McPhee, D. A., et al.. (1996). Response : Attenuated HIV Vaccine: Caveats. Science. 271(5257). 1791–1792. 4 indexed citations
14.
McLaws, Mary‐Louise, et al.. (1995). Heterosexually acquired HIV infection in female blood donors: Case series between 1985-1990. AIDS Care. 7(5). 631–638.
15.
Sullivan, John, et al.. (1995). A Direct Association between HIV and AIDS in Blood Transfusion Donors and Recipients. AIDS Research and Human Retroviruses. 11(10). 1147–1148. 3 indexed citations
16.
Deacon, Nicholas J., Anna Tsykin, A. Solomon, et al.. (1995). Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients. Science. 270(5238). 988–991. 982 indexed citations breakdown →
17.
Kaldor, John, et al.. (1994). HIV infection in recipients of blood products from donors with known duration of infection. The Lancet. 344(8924). 718–720. 20 indexed citations
18.
Becker, Niels G., et al.. (1994). Non‐parametric analysis of transfusion‐related HIV and AIDS incidence data. Statistics in Medicine. 13(19-20). 2043–2058. 2 indexed citations
19.
Learmont, Jennifer C., B. Tindall, John Kaldor, et al.. (1992). Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. The Lancet. 340(8824). 863–867. 183 indexed citations
20.
Dwyer, John M., et al.. (1990). Susceptibility of postmenopausal women to infection with HIV during vaginal intercourse. The Medical Journal of Australia. 153(5). 299–299. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026